1. Erratum to "Phase I, randomized, observer-blind, placebo-controlled studies to evaluate the safety, reactogenicity and immunogenicity of an investigational non-typeable Haemophilus influenzae (NTHi) protein vaccine in adults" [Vaccine 34 (2016) 3156–3163]. Issue 42 (9th October 2017) Authors: Leroux-Roels, Geert; Van Damme, Pierre; Haazen, Wouter; Shakib, Sepehr; Caubet, Magalie; Aris, Emmanuel; Devaster, Jeanne-Marie; Peeters, Mathieu Journal: Vaccine Issue: Volume 35:Issue 42(2017) Page Start: 5729 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Evaluation of the immunogenicity of the dabigatran reversal agent idarucizumab during Phase I studies. (6th April 2017) Authors: Norris, Stephen; Ramael, Steven; Ikushima, Ippei; Haazen, Wouter; Harada, Akiko; Moschetti, Viktoria; Imazu, Susumu; Reilly, Paul A.; Lang, Benjamin; Stangier, Joachim; Glund, Stephan Journal: British journal of clinical pharmacology Issue: Volume 83:Number 8(2017) Page Start: 1815 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗